| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |